Table 1.

Randomized clinical trials of autologous HSCT in autoimmune disease

Randomized clinical trials of autologous HSCT in autoimmune disease
Randomized clinical trials of autologous HSCT in autoimmune disease

CYC, indicates cyclophosphamide; IVI, intravenous infusion.

Close Modal

or Create an Account

Close Modal
Close Modal